Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Receivables for the year ending December 31, 2023: USD 0.00

Shanghai Haoyuan Chemexpress Co., Ltd. Receivables is USD 0.00 for the year ending December 31, 2023, a -100.00% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Shanghai Haoyuan Chemexpress Co., Ltd. Receivables for the year ending December 31, 2022 was USD 53.04 M, a 123.48% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Receivables for the year ending December 31, 2021 was USD 23.73 M, a 75.79% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Receivables for the year ending December 31, 2020 was USD 13.50 M, a 53.73% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Receivables for the year ending December 31, 2019 was USD 8.78 M, a 38.93% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years